Concert Pharmaceuticals Inc (CNCE) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Concert Pharmaceuticals Inc   (NASDAQ: CNCE)


Concert Pharmaceuticals Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Concert Pharmaceuticals Inc's ROI in the third quarter of 2022?
Concert Pharmaceuticals Inc recorded a cumulative net loss of $-186 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -128.55%.

Within the Healthcare sector 957 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 0 to 4990.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM 7.54 % -4.74 % -11.78 % -14.81 % -10.74 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 154 160 114 149 116
Return On Investment (TTM) -128.55 % -155.61 % -134.8 % -119.23 % -65.23 %
CNCE's Overall Ranking # 4990 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 6.95 % 3.89 % -3.23 % 0.02 % -5.26 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -186 -210 -175 -160 -88

CNCE Company Profile >> Back to CNCE Roi Comparisons >> See Annual CNCE Return On Investment



Return On Investment CNCE's Ranking
Within: No.
Industry # 466
Sector # 958
Overall # 4990

Return On Investment Statistics
High Average Low
53.54 %
-42.35 %
-155.61 %
(Jun 30 2018)   (Jun 30 2022)







Financial Statements
Concert Pharmaceuticals Inc's III. Quarter Investments $ 154 Millions CNCE's Balance sheet
Concert Pharmaceuticals Inc's III. Quarter Income $ -29 Millions Quarterly CNCE's Income Statement
CNCE's Income by Division See CNCE's Income by Division


CNCE Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 149 149 120 184 205
Y / Y Investment Growth 0.07 % 24.03 % -34.6 % -10.47 % 116.49 %
Net Income in Millions -160 0 0 0 95
Y / Y Net Income Growth - 150 % - - -
Annual Return On Investment -107.31 % 0.06 % 0.03 % -0.17 % 46.37 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CNCE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CNCE's Competitors
Subscribers only: Roi for Concert Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for CNCE's Customers

Other Ratios
CNCE's Roa CNCE's Inventory Turnover Ratio CNCE's Growth Rates CNCE's Dividend Statistics
CNCE's Profitability Ratios CNCE's Asset Turnover Ratio CNCE's Dividend Growth
CNCE's Roe CNCE's Valuation Ratios CNCE's Financial Strength Ratios CNCE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI

Date modified: 2026-08-30T06:40:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.